journal
Journals Current Opinion in Endocrinolo...

Current Opinion in Endocrinology, Diabetes, and Obesity

https://read.qxmd.com/read/37983310/health-economics-of-detection-and-treatment-of-children-with-familial-hypercholesterolemia-to-screen-or-not-to-screen-is-no-longer-the-question
#21
JOURNAL ARTICLE
Clara Marquina, Jedidiah I Morton, Zanfina Ademi
PURPOSE OF REVIEW: Heterozygous familial hypercholesterolemia (HeFH) is one of the most common monogenic disorders and is safely treatable with lipid-lowering medication. However, most individuals with HeFH remain untreated and undetected, especially in paediatric populations where the potential for long-term therapeutic benefit is higher. Here, we review the recent literature on health economic outcomes for the detection and management of FH in children. RECENT FINDINGS: A targeted literature review identified eight studies evaluating detection and management strategies for paediatric FH populations in the last 25 years...
November 21, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37882585/addressing-disparities-in-technology-use-among-patients-with-type-1-diabetes-a-review
#22
JOURNAL ARTICLE
Sarah Kanbour, Estelle Everett
PURPOSE OF REVIEW: The benefits of continuous glucose monitors (CGMs) and insulin pumps in the management of type 1 diabetes are widely recognized. However, glaring disparities in access exist, particularly in groups that stand to benefit significantly from diabetes technology use. We will review recent data describing drivers of these disparities and approaches to address the disparities. RECENT FINDINGS: Several qualitative studies were published in recent years that have investigated the drivers of disparities reported over the past decades...
October 26, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37800439/integrating-psychosocial-and-behavioral-interventions-into-type-1-diabetes-care
#23
JOURNAL ARTICLE
Elizabeth A Pyatak, Anya R Khurana
PURPOSE OF REVIEW: To identify recent literature evaluating the efficacy of psychosocial and behavioral interventions for people with type 1 diabetes (T1D). RECENT FINDINGS: Interventions generally produce benefits for psychosocial and behavioral outcomes, and some also positively impact glycemia. Addressing psychosocial concerns during routine provider visits had mixed results; some studies found that structured tools improved well being, while others found they could derail conversations, or contribute to worsening glycemia due to a lack of time to review medical concerns...
October 7, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37678177/updates-in-thyroid-healthcare-delivery-advancing-patient-centered-care
#24
JOURNAL ARTICLE
Maria Papaleontiou, Megan R Haymart
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37530703/molecular-testing-for-indeterminate-thyroid-nodules-past-present-and-future
#25
REVIEW
Rajam Raghunathan, Stephanie Smooke Praw, Masha Livhits
PURPOSE OF REVIEW: To examine the origin, current progress, and future directions of molecular testing in indeterminate Bethesda III and Bethesda IV thyroid nodules. RECENT FINDINGS: The diagnostic performance of current genomic tests shows improved benign call rates, specificity and positive-predictive values over prior test versions. The choice of test platform for clinical use should consider test performance, institutional rate of malignancy, nodule cytology and the potential for prognostication to help guide decision-making...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37417826/an-update-maternal-iodine-supplementation-thyroid-function-tests-and-child-neurodevelopmental-outcomes
#26
REVIEW
Caroline T Nguyen
PURPOSE OF REVIEW: The impact of maternal iodine supplementation (MIS) during pregnancy on thyroid function and child neurodevelopmental outcomes in areas of mild-to-moderate iodine deficiency (MMID) remains unclear. RECENT FINDINGS: Despite growing success of salt iodization programs, a 2022 meta-analysis found that 53% of pregnant patients worldwide continue to have insufficient iodine intake during pregnancy. A 2021 randomized controlled trial (RCT) found that MIS in women with mild iodine deficiency led to iodine sufficiency and positive effects on maternal thyroglobulin...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37410453/recent-advances-in-anaplastic-thyroid-cancer-management
#27
REVIEW
Sarah Hamidi, Anastasios Maniakas
PURPOSE OF REVIEW: To summarize recent developments in the diagnosis and management of patients with anaplastic thyroid cancer (ATC). RECENT FINDINGS: An updated edition of the Classification of Endocrine and Neuroendocrine Tumors was released by the World Health Organization (WHO), in which squamous cell carcinoma of the thyroid are now a subtype of ATC. Broader access to next generation sequencing has allowed better understanding of the molecular mechanisms driving ATC and improved prognostication...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37288727/cardiovascular-outcomes-in-subclinical-thyroid-disease-an-update
#28
REVIEW
Matthew D Ettleson
PURPOSE OF REVIEW: Subclinical thyroid disease is defined by a thyroid stimulating hormone (TSH) level outside of the normal range with normal circulating thyroid hormone levels. Excess adverse cardiovascular outcomes have been observed in certain patient populations with subclinical hypothyroidism (SCH) and hyperthyroidism (SCHr). The role of thyroid hormone and antithyroid treatments for subclinical thyroid disease remains debated. RECENT FINDINGS: Cardiovascular disease appears to be a major mediator of all-cause mortality in patients with SCH, in particular those aged at least 60 years of age...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37732930/assisted-reproductive-technology-outcomes-and-management-considerations-for-people-with-epilepsy
#29
JOURNAL ARTICLE
Regan J Lemley, Paula Emanuela Voinescu
PURPOSE OF REVIEW: Epilepsy is a common neurologic condition amongst people with reproductive capacity, and assisted reproductive technology (ART) is being increasingly utilized. A recent population-based study described favorable outcomes of ART in this population, but other work shows how fluctuating sex hormones may influence medication concentrations and seizures. RECENT FINDINGS: This review discusses hormonal influences on epilepsy and catamenial epilepsy, considerations regarding fertility in women with epilepsy, emerging ART outcomes, and management considerations for people with epilepsy undergoing ART...
September 22, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37646503/a-review-of-recent-evidence-on-androgen-abuse-from-interviews-with-users
#30
JOURNAL ARTICLE
Bonnie Grant, Suks Minhas, Channa N Jayasena
PURPOSE OF REVIEW: Androgens (also known as anabolic-androgenic steroids; AAS) are increasingly being abused worldwide to enhance body physique or athletic performance. Qualitative studies including interviews provide a wider understanding of androgen abuse and focus specific support needs to this group. This narrative review summarizes recent studies (2021-2023) using interviews with individuals abusing androgens. RECENT FINDINGS: Motivations for androgen abuse in men include desires to achieve certain physicality, enhance self-confidence and improve libido...
September 7, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37603040/surveys-on-androgen-abuse-a-review-of-recent-research
#31
JOURNAL ARTICLE
Kyle T Ganson, Jason M Nagata
PURPOSE OF REVIEW: To summarize recent survey research on androgen abuse [i.e., anabolic-androgenic steroids (AAS)], including prevalence among international samples, risk factors for use, associated impairments of use, and treatment and interventions for abusers. RECENT FINDINGS: Recent research has documented the prevalence of androgens abuse remains most common among boys and men compared to girls and women, which was stable across nations. However, fewer studies have focused on population-based samples and instead focused on convenience or high-risk samples (i...
August 22, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37382469/skeletal-health-in-diabetes
#32
JOURNAL ARTICLE
Viral N Shah
No abstract text is available yet for this article.
August 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37382468/editorial-introduction
#33
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37335282/mr-based-techniques-for-intracortical-vessel-visualization-and-characterization-understanding-the-impact-of-microvascular-disease-on-skeletal-health
#34
REVIEW
Maximilian T Löffler, Po-Hung Wu, Galateia J Kazakia
PURPOSE OF REVIEW: The relationships between bone vasculature and bone microstructure and strength remain incompletely understood. Addressing this gap will require in vivo imaging capabilities. We describe the relevant vascular anatomy of compact bone, review current magnetic resonance imaging (MRI)-based techniques that allow in vivo assessment of intracortical vasculature, and finally present preliminary studies that apply these techniques to investigate changes in intracortical vessels in aging and disease...
August 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37334507/effect-of-incretins-on-skeletal-health
#35
REVIEW
Jakob Starup-Linde, Katrine Hygum, Bente Langdahl
PURPOSE OF REVIEW: The incretin hormones, glucagon like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP), have been shown to decrease bone resorption in humans. The aim of this review is to collate evidence and current advances in the research within the last year on the effect of incretins on skeletal health. RECENT FINDINGS: Preclinical studies show potential direct beneficial effects on bone by GLP-1 and GIP, however real world epidemiological data show no effects of GLP-1 receptor analogues on fracture risk...
August 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37248797/prediabetes-and-skeletal-health
#36
REVIEW
Catherine Lindsay, Albert Shieh
PURPOSE OF REVIEW: Type 2 diabetes mellitus (T2D) confers a greater risk of skeletal fragility and fracture. Whether prediabetes is detrimental to bone health is uncertain. RECENT FINDINGS: We summarize the current data on the associations of prediabetes with bone turnover, bone mineral density, bone quality, bone material properties and fracture risk. SUMMARY: In cross-sectional studies, prediabetes was associated with lower bone turnover and worse trabecular bone quality...
August 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37132326/effects-of-very-low-carbohydrate-ketogenic-diets-on-skeletal-health
#37
REVIEW
Cora M Best, Simon Hsu
PURPOSE OF REVIEW: Very low carbohydrate ketogenic diet (KD) therapy has been associated with skeletal demineralization in children with drug-resistant epilepsy, but the cause of this association is unclear. Recently, interest in the KD has grown owing to its potential benefits for other illnesses including cancer, type 2 diabetes, obesity, and polycystic kidney disease. Summaries of the best available evidence regarding effects of a KD on skeletal health are lacking. RECENT FINDINGS: Recent rodent studies found that a KD can harm the growing skeleton, which corroborates most but not all studies in pediatric patients...
August 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37470486/financial-toxicity-in-thyroid-cancer-survivors
#38
JOURNAL ARTICLE
Anastasia K Bogdanovski, Cord Sturgeon, Benjamin C James
PURPOSE OF REVIEW: Financial burden and distress are high in patients with thyroid cancer. However, little has been done to evaluate potential interventions to mitigate financial toxicity in survivors. This review will cover current data on the impact of financial toxicity on quality of life and clinical outcomes in patients with thyroid cancer and highlight areas for future study. RECENT FINDINGS: Thyroid cancer incidence has nearly tripled in the past decades, and cost of treatment is predicted to rise more than other cancers over the next decade...
July 20, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37410490/prevalence-and-correlates-of-androgen-dependence-a-meta-analysis-meta-regression-analysis-and-qualitative-synthesis
#39
JOURNAL ARTICLE
Jenny Eriksrød Skauen, Ståle Pallesen, Astrid Bjørnebekk, Razieh Chegeni, André Syvertsen, Andrea Petróczi, Dominic Sagoe
PURPOSE OF REVIEW: To investigate the prevalence and correlates of androgen dependence among users. A meta-analysis, meta-regression analysis, and qualitative synthesis were conducted based on a systematic literature search in Google Scholar, ISO Web of Science, PsycNET, and PubMed. RECENT FINDINGS: Twenty-six studies were included in the review and 18 studies (N = 1782) in the statistical analysis. The overall lifetime androgen dependence prevalence was 34...
July 7, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37410455/obesity-and-thyroid-cancer-risk
#40
JOURNAL ARTICLE
Lauren C Burrage, Donald S A McLeod, Susan J Jordan
PURPOSE OF REVIEW: This review explores recent evidence assessing the relationship between obesity and thyroid cancer. RECENT FINDINGS: Consistent evidence from observational studies suggests that obesity increases the risk of thyroid cancer. The relationship persists when alternative measures of adiposity are used, but the strength of association may vary according to the timing and duration of obesity and how obesity or other metabolic parameters are defined as exposures...
July 7, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
journal
journal
41662
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.